Preben Bruun-Nyzell

Preben Bruun-Nyzell is an executive with more than 20 years international experience. In addition to his role in 2N Pharma, he is co-founder and CEO of the clinical stage vaccine company 2A Pharma and chairman of Apoglyx which specialises in medical applications of aquaporin inhibitors.